HHFT Sponsored Studies

Hampshire Hospitals proudly sponsors research designed and carried out by our own staff. Being a sponsor means we oversee the quality and governance of the study to ensure it meets the high standards expected. We are the sponsor for the following studies:

  • Cryocompression methods following ACLr: an RCT This study is comparing the use of an ice pack or an electronic cryocompression device for patients who have undergone ACL Reconstruction.
  • NET Cancer - a data study used to determine mode of presentation, route to diagnosis, updated incidence, prevalence and survival of patients with Neuroendocrine Neoplasia, calculating total costs of care
  • Reversibility of Chemotherapy Associated Liver Injury is a study that looks to trace the impact of two or more liver re-sections through analysis of histological liver specimens taken during surgery to treat colorectal liver metastases.

 

Studies from our Peritoneal Malignancy Institute:

  • HaemoCue - Objective Measurement of Blood Loss During Cytoreductive Surgery (CRS) A pilot study to see if we can objectively measure blood loss during Cytoreductive Surgery and HIPEC, which is used to treat Pseudomyxoma Peritonei, using a device called HaemoCue.
  • Molecular and cytogenetic characterisation of peritoneal surface malignancies a study looking at the basic molecular defects that are characteristic for the disease spread of cancer to the peritoneum.
  • PRECINCT an observational study collecting standard of care data to find correlations that may predict the patterns of peritoneal disease.
  • Overwhelming Post-splenectomy Infections (OPSI) a study observing how often patients report an infection after having their spleen removed during a specific surgery used to treat Pseudomyxoma Peritonei.
  • Predicting recurrence of PMP arising from LAMN using Machine Learning a study using data to create a model to predict risk factors for Pseduomyxoma Peritonei

Accessibility tools

Return to header